Ampio Pharmaceuticals Inc (AMPE)
NYSE
Closed
Aug 21, 2026
Day's Range
0.183152 wk Range
0.00270Overview - AMPE - Ampio Pharmaceuticals Inc
Key Statistics
Valuation
Enterprise Value
-3.46M
P/E (Forward)
‪-2.03‬
PEG Ratio
‪-2.03‬
Price / Book
‪0.04‬
EV / EBITDA
‪0.36‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-61.56%‬
Return on Equity
‪-113.96%‬
Ownership
Shares Outstanding
833.43K
Float
1.11M
Short % of Shares Outstanding
‪2.94%‬
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪17.90‬
50-Day Avg
‪0.1831‬
200-Day Avg
‪0.1449‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMPE - Ampio Pharmaceuticals Inc
Peers - AMPE - Ampio Pharmaceuticals Inc
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- AMPENYSEAmpio Pharmaceuticals Inc207.88KMarket Cap+98.53%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.10.16BMarket Cap+21.75%52-week change46.50P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.2.09BMarket Cap-7.87%52-week change-2.02P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.72BMarket Cap+20.82%52-week change6.90P/E (Trailing)‪0.00%‬Profit Margin
- ANRONYSEAlto Neuroscience Inc.1.34BMarket Cap+88.51%52-week change-15.62P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust1.00BMarket Cap+25.06%52-week change4.60P/E (Trailing)‪0.00%‬Profit Margin
- ATTONYSEAttovia Therapeutics Inc.895.00MMarket Cap-5.29%52-week change-8.78P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - AMPE - Ampio Pharmaceuticals Inc
About
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
